Home › NDC Lookup › RxCUI directory › RxCUI 312818

Ribavirin 20 MG/ML Inhalation Solution — RxCUI 312818

Name: Ribavirin 20 MG/ML Inhalation Solution (RxCUI 312818)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 312818 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312818

Official nameRibavirin 20 MG/ML Inhalation Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asribavirin 6 GM Inhalation Solution

FDA products mapped4

Package NDCs mapped5

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ribavirin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It depends on the form. Tablets and capsules are used with an interferon medicine to treat chronic hepatitis C. The inhaled form is used in hospitals for severe RSV lung infections...
Take them by mouth with food, usually split into two doses a day, as your prescriber directs. Don't open, crush or break the capsules. Keep taking your interferon medicine as presc...
How should I take my ribavirin tablets or capsules?
Tiredness, headache, fever and chills, nausea, muscle aches, trouble sleeping and mood changes are common. Many of these come partly from the interferon it's paired with. Call us i...

📖 Read our full Ribavirin guide →

🕸️ Concept Web — How Ribavirin 20 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Ribavirin 20 MG/ML Inhalation Solution RxCUI 312818 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Ribavirin 9344 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Virazole 204276 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ribavirin Inhalation Solution 2108389 SCDF
- Ribavirin Inhalant Product 1165446 SCDG
- Ribavirin Inhalation Solution [Virazole] 2108391 SBDF
- Virazole Inhalant Product 1186972 SBDG
- Inhalation Solution 346161 DF
- Inhalant Product 1151123 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Ribavirin 20 MG/ML 340195 SCDC
- Ribavirin 20 MG/ML Inhalation Solution [Virazole] 207406 SBD
- Ribavirin 20 MG/ML [Virazole] 568171 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Ribavirin 20 MG/ML SCDC · 340195
Ribavirin Inhalation Solution SCDF · 2108389
Ribavirin Inhalant Product SCDG · 1165446

Brand-Name Concepts

Ribavirin 20 MG/ML Inhalation Solution [Virazole] SBD · 207406
Ribavirin 20 MG/ML [Virazole] SBDC · 568171
Ribavirin Inhalation Solution [Virazole] SBDF · 2108391
Virazole Inhalant Product SBDG · 1186972
Virazole BN · 204276

📦 FDA Products & Package NDCs

4 products · 5 package NDCs

5 package NDCs map to RxCUI 312818 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
68382-0395-04	4 VIAL in 1 CARTON (68382-395-04) / 1 POWDER, FOR SOLUTION...	RIBAVIRIN	Zydus Pharmaceuticals USA Inc.	2016-12-15
68475-0003-04	4 VIAL in 1 CARTON (68475-003-04) / 1 POWDER, FOR SOLUTION...	RIBAVIRIN	Navinta LLC	2020-04-21
68682-0019-01	1 VIAL, GLASS in 1 CARTON (68682-019-01) / 1 POWDER, FOR SO...	Ribavirin	Oceanside Pharmaceuticals	2019-08-27
68682-0019-06	4 VIAL, GLASS in 1 CARTON (68682-019-06) / 1 POWDER, FOR SO...	Ribavirin	Oceanside Pharmaceuticals	2017-04-14
72162-1331-02	1 VIAL, GLASS in 1 CARTON (72162-1331-2) / 1 POWDER, FOR SO...	Ribavirin	Bryant Ranch Prepack	2024-02-09

Observed labelers: Oceanside Pharmaceuticals (2) · Bryant Ranch Prepack (1) · Navinta LLC (1) · Zydus Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.